Health
AIDS drug funds threatened by Tea Party scare?
White House, Hill leaders reluctant to push emergency measure
Some Democrats and Republicans in Congress who have long supported funding for the AIDS Drug Assistance Program are reluctant to back the struggling program this year because they fear the additional spending will jeopardize their chances of being re-elected, Capitol Hill observers and AIDS activists said this week.
William Arnold, executive director of the National ADAP Working Group, said intense pressure on members of Congress to curtail spending by the so-called Tea Party movement has made it difficult to line up support for an emergency supplemental appropriation measure.
Arnold and officials with other national AIDS and LGBT organizations say the program is facing a crisis never seen before, where a growing number of low income people with HIV or AIDS may be denied life-saving anti-retroviral drugs in at least 11 states this year because state ADAP affiliates have run out of money.
Due to a shortage of funds, the 11 states have been forced to put in place waiting lists for patients who otherwise would have received AIDS medication prescribed by their doctors.
“It’s ridiculous that people have to be wait-listed for medicine that they need to stay alive,” said Laurie Young, a policy analyst for the National Gay & Lesbian Task Force.
ADAP was created in 1987 under the Ryan White Care Act to help pay for AIDS-related drugs for low-income people with HIV/AIDS, including those who don’t have health insurance coverage.
Advocacy groups familiar with the program say an emergency appropriation of at least $126 million is needed this year to provide AIDS drugs for all that need them. But they say the Obama administration and Democratic leaders in Congress have yet to make a commitment to back such an appropriations measure.
Nearly 80 members of the House, including gay Reps. Barney Frank (D-Mass.) and Tammy Baldwin (D-Wisc.), signed a petition recently sent to the White House urging the president to back the emergency funding measure. All but one of the House members signing the petition were Democrats.
Baldwin said Tuesday that she and her colleagues who signed the petition have yet to receive a response from the White House.
In an e-mail Tuesday to the Blade, White House spokesperson Shin Inouye said the president “strongly supports the Ryan White Program and the AIDS Drug Assistance Program’s vital role in providing life-saving medications for people living with HIV and AIDS.”
Inouye noted that the current year’s funding for ADAP represents a $20 million increase over the fiscal year 2009 funding. He said President Obama has proposed an increase in ADAP funding for next year that will allow the program to “serve an additional 3,389 individuals.”
But Inouye didn’t say whether the administration would support the $126 million emergency supplemental appropriation for ADAP for this year, as AIDS groups have requested.
In response to a request for the White House’s position on the emergency funding proposal, Inouye said, “We are working to ensure that ADAP has the funds it needs so that waiting lists are not needed for this safety net program.”
Drew Hammill, a spokesperson for House Speaker Nancy Pelosi, said Pelosi and other House Democratic leaders were reviewing the request.
“As she has every single year since the program was created, the speaker will push for increased funding for ADAP in the regular [fiscal year] 2011 Labor-[Health & Human Services]-Education appropriations bill,” he said.
Representatives of AIDS groups, including Arnold, said a funding increase in the fiscal year 2011 appropriations bill cited by Pelosi’s office would be helpful and could alleviate the ADAP crisis if the funding were large enough.
But they said that immediate relief is needed this year, noting that the 2011 measure would not take effect until July 1, 2011.
Baldwin told the Blade that she was certain that congressional Democrats would take steps to support the $126 million emergency appropriation. But she said Republicans in the House have followed a policy of opposing nearly all spending bills proposed by Democrats.
“I sense among the Democratic caucus, among the Democratic leadership, an absolute awareness of this” funding problem and a commitment to acting, she said. “And yet when we can’t rely on any bipartisanship to respond to this crisis, we can’t rely on a single Republican vote to help respond to the absolute needs of people we represent, it is extremely challenging.”
But Michael Weinstein, president of the AIDS Healthcare Foundation, questioned Baldwin’s response, saying Democrats have yet to introduce a measure calling for the $126 million funding for ADAP.
“Why don’t they introduce a bill and call the Republicans’ bluff if they want to blame this on the Republicans?” Weinstein said.
He noted that Sens. Richard Burr (R-N.C.) and Tom Coburn (R-Okla.) introduced a bill last month that would take the $126 million needed for ADAP this year from the federal stimulus program, where there are millions of dollars in unobligated funds.
Sens. Michael Enzi (R-Wyo.) and George LeMieux (R-Fla.) also signed onto the bill, but no Democrats so far have agreed to become co-sponsors. Weinstein said Democratic sources in the Senate told him the bill would be “dead on arrival” when sent to a committee to consider it.
“This is partisan politics, with the well-being of people with AIDS the ones to suffer the consequences,” Weinstein said.
Weinstein also challenged Pelosi to immediately introduce an emergency funding measure to cover the needed funds for ADAP this year, saying her district in San Francisco has a large number of low-income people with HIV that rely on ADAP.
He acknowledged, though, that no other Republican senator, including Senate Minority Leader Mitch McConnell, have signed on to the Burr-Coburn bill. A similar bill has yet to be introduced in the House.
Baldwin said she would likely vote for such a bill if it were introduced in the House and became the only vehicle to allocate the ADAP funds. However, she noted that she would prefer not to take funds from the stimulus program.
In his e-mail to the Blade, Inouye said the White House opposes taking funds from the stimulus program “because those resources are needed by communities across the country to keep the economic recovery going and to stimulate job growth.”
Arnold said his group supports the Burr-Coburn bill on grounds that it could provide immediate help for ADAP and the funds are already incorporated in the federal budget, preventing the need for “more spending” to appropriate the funds.
He also noted that the Tea Party movement appears to have frightened both Republicans and Democrats from embracing new spending, even if they know it’s needed to help save lives.
Some Capitol Hill insiders have said the reluctance by lawmakers to back spending measures appears to have stopped a supplemental appropriations bill normally approved each year to pay for federal disaster relief efforts. AIDS activists were hoping a supportive committee member would seek to add the ADAP emergency appropriation to this bill.
That bill, which was before the House Appropriations Committee, was expected to come up for a committee vote last month, just before Memorial Day. But Arnold and other sources familiar with the measure said Committee Chair David Obey (D-Wis.) reportedly put the bill on “hold” because he couldn’t line up the votes among his fellow Democrats to pass it.
Moderate and conservative Blue Dog Democrats were among those reluctant to back the bill, said people familiar with the measure.
“The Blue Dog Democrats have been very opposed to spending money, period, because they’re worried about getting re-elected and they’re from swing districts where tea partiers might be challenging them,” Arnold said.
Obey reportedly has said he postponed committee consideration of the bill because too much business was taking place on the House floor and committee members didn’t have time to consider the bill, according a source familiar with the committee. The source said Obey indicated he would soon decide how and when to take up the bill.
Arnold said his and other AIDS groups have argued that turning down the ADAP spending measure would be “penny wise and pound foolish” because it saves the government large sums of money in the long run.
If people with AIDS are denied medication, they could end up in the hospital, and state and federal agencies could be forced into picking up the bill from patients without insurance coverage.
Health
United States Conference on HIV/AIDS grapples with federal budget cuts
Annual gathering is largest of its kind in the country
Advocates, public health experts, and healthcare providers gathered for the United States Conference on HIV/AIDS on Sept. 17 in Anaheim, Calif.
The conference is the largest of its kind in the nation and came amid a wave of new challenges for HIV research and treatment. Since the beginning of the second Trump-Vance administration, federal spending cuts have targeted HIV/AIDS programs, including the gutting of the U.S. Agency for International Development and proposed cuts to PEPFAR, which supports HIV testing and treatment globally, in 2025.
Last year, Congress maintained funding for HIV programs after proposed cuts faced opposition from advocacy groups and bipartisan criticism. Yet, this year Congress has proposed similar cuts to many of the same programs, which would cut nearly one billion dollars in HIV funding. The majority of the cuts would impact HIV prevention and outreach, which includes ending nearly all Centers for Disease Control and Prevention HIV prevention activities.
“If we continue down this path,” said Jeremiah Johnson, the executive director of PrEP4ALL, an advocacy group that supports expanding access to HIV prevention. “We’re going to see more people falling off treatment. We’re going to see more wait lists. That’s going to lead to more people dying from AIDS-related complications.”
Cuts and challenges
The funding cuts loomed over the conference and inspired protest from activists.
On the first day of USCHA, activists with Save HIV Funding organized a mock funeral outside the convention center. Advocates living with HIV wrote eulogies for themselves, meant to show the consequences of diminished access to treatment. Then activists marched through the conference carrying fake coffins.
Johnson, who helped organize the protest, said that “the Trump administration has eviscerated global aid … and the fears that many of us are just talking about hypothetically for ourselves at the moment are already happening [internationally]. And so we wanted to place that front and center at this conference.”
The attacks on funding for HIV research and outreach come at a complicated time for the movement to end the AIDS epidemic. While options for prevention and treatment have never been more accessible, such as PrEP and antiretroviral therapy, there have been some concerning upticks in infections, particularly among communities of color.
Southern states account for the majority of new HIV infections in the country, despite making up only 38 percent of the population. And these infections impact disproportionately Black and Latino communities. According to the CDC, even as overall HIV infections decreased from 2018 to 2022, diagnoses of HIV among Latinos grew by 17 percent, with a majority of this increase happening in the South.
Stigma is still the biggest barrier for people seeking out HIV treatment, said Guillermo Chacón, president of the Latino Commission on AIDS.
“The progress that we [made] in the past two years has been demolished,” he said.
Chacón blames the federal government for stigmatizing HIV treatment by using harmful rhetoric about queer people.
“The level of homophobia and transphobia right now is even higher because it has been used as a political message to create fear and division in our country,” he said.
Chacón believes that research and outreach must be done to reverse the rising HIV infections among Latinos. However, this is exactly the type of research that the Trump-Vance administration is targeting most intensely. Research into “health disparities” — why some health problems impact certain communities more than others — has been heavily criticized by the White House, along with other research that it considers “woke” and claims is not supported by science.
Impact felt at conference
The opening plenary for the conference addressed some of the funding challenges the movement was facing but tried to shift the focus to the victories the movement has seen over the years. Speakers highlighted historic successful activist campaigns like ACT UP, and recent improvements in medical care and access to treatment.
Randevyn Pierre, head of U.S. external affairs at ViiV Healthcare, the sponsor of the plenary, took the stage to celebrate the success of the U = U campaign (undetectable viral load =
untransmittable HIV virus), and ViiV’s investment of $33 million in HIV community organizations across the U.S. This comes as the Trump-Vance administration has made moves to end direct funding of community-based organizations, opting to give the funding to state healthcare agencies.
The speakers at the conference discussed reducing stigma for those living with HIV and the joy of living authentically. They also emphasized the diverse groups of people that are impacted by HIV and how they can come together to fight for a cure. Longtime AIDS activist Rae Lewis Thorton exclaimed, “When they tell me there’s a cure to HIV, I’m gonna take off my 4-inch heels and put on gold slippers,” to applause from the audience.
The opening plenary also featured song and dance from a variety of artists, many of whom spoke about how HIV has impacted their own lives and how advocacy has uplifted their spirits. However, the joyous atmosphere at the conference would not last.
On the final day of USCHA, Geri Donenberg, the associate director of AIDS research at the National Institutes of Health, took the stage to address the conference.
As she spoke, phones began to buzz around the room with breaking news: the Trump-Vance administration was drafting an executive order to create an external board to oversee NIH grants and screen them for political content. NMAC CEO Harold Philips took the stage after Donenberg to address the crowd. “It’s up to us,” Philips said, “to hold NIH accountable.” He added that HIV advocates “have supporters inside NIH who are struggling and working to do the right thing. We have to have their back.”
Chants of “stand up, fight back, fight AIDS” erupted from the crowd as Philips spoke. “We do have to fight back. We do have to continue to fight,” Philips replied.
Caleb Kaufman is a California Local News Fellow placed with the Los Angeles Blade. The California Local News Fellowship is a state-funded initiative to support and strengthen local news reporting. Learn more about it at fellowships.journalism.berkeley.edu/cafellows.
Health
AIDS Healthcare Foundation announces 3 million people globally in its care
Los Angeles-based group lauded ‘historic milestone’
The AIDS Healthcare Foundation, a Los Angeles-based nonprofit group founded in 1987 that has become the world’s largest HIV/AIDS organization, has announced it has three million people in care around the world.
In a statement released on May 26, the organization, known worldwide as AHF, said the latest accomplishment reflects its global commitment to HIV prevention, care, and treatment. It says the accomplishment comes at a time when AHF marks the 25th anniversary of its first global programs launched in South Africa and Uganda in early 2001.
The statement says the three million people in care milestone also comes while the group approaches the 40th anniversary of its founding in 1987.
“Today, AHF provides lifesaving services in 50 countries across Africa, the Americas, Asia, and Europe, supporting millions of people living with HIV through a network of 1,056 global clinics, 79 healthcare centers in the U.S., 67 pharmacies, 96 wellness centers, 26 Out of the Closet thrift stores, outreach programs, and community partnerships,” the statement says.
“This accomplishment is far more than a number — it represents 3 million individuals whose lives have been touched by compassion, commitment, and the belief that healthcare is a human right,” Condessa M. Curley, the AHF board chair, said in a statement. “We extend our deepest gratitude to every member of the AHF team whose dedication made this milestone possible,” Curley said.
The AHF website notes the organization was founded in 1987 in Los Angeles as a network of hospices committed to “fighting for the living and caring for the dying” at a time when there was no effective treatment for HIV/AIDS. A statement on the website says since that time AHF has greatly expanded, converting its hospices into healthcare centers “and building a new paradigm for HIV care both in the United States and around the world.”
The statement adds, “Under the leadership of president and co-founder Michael Weinstein, AHF has grown from a group of friends dedicated to creating dignified hospice care to the largest AIDS organization in the world.” It says Weinstein “has been at the forefront of creating cutting-edge healthcare and advocacy programs and continues to drive the organization forward with the aim of saving more lives around the world.”
The statement announcing the milestone has also come at a time when more than 40 million people worldwide are living with HIV, “while hundreds of thousands continue to die annually from AIDS-related illnesses despite the availability of effective treatment.”
It says AHF’s response has included an expansion of its prevention and public health programs worldwide. In 2025 alone, according to the statement, AHF and its affiliated programs provided nearly five million free HIV tests globally and distributed more than 54 million free condoms, “underscoring the organization’s continued emphasis on both prevention and treatment.”
In D.C. AHF operates health care centers at 1701 K St., N.W., Ste. 400 [202-293-8680], 650 Pennsylvania Ave., S.E., Ste. 310 [202-350-5000], and 1647 Benning Road, N.E., Ste. 300 [202-350-5000].
Cannabis Culture
LGBTQ people, weed, and mental health: what you need to know
Community uses marijuana at much higher rates than general population
Uncloseted Media published this story on May 7.
By SPENCER MACNAUGHTON | In 2025, the global cannabis market size was valued at nearly $103 billion. By 2034, that number is expected to explode by roughly 1,400 percent to more than $1.43 trillion.
In short, as an increasing number of countries legalize marijuana use, everyone is starting to consume a lot more weed. And LGBTQ people tend to use cannabis at much higher rates than the general population. One study found that 55 percent of lesbian and 45 percent of gay young adults use marijuana, compared to about 33 percent and 37 percent, respectively, of their straight counterparts.
As LGBTQ people face a mental health crisis, the mainstream stereotypes that depict weed as an antidote for anxiety, panic and depression aren’t painting the full picture. And that could be exacerbating the mental health struggles so many queer people, and especially youth, face.
Here’s what the research demonstrates about marijuana and its effects on mental health:
- Multiple studies suggest a link between marijuana use and an increased risk of mental health disorders, including schizophrenia, depression and anxiety in individuals who are genetically predisposed.
- One study found that daily marijuana use, especially among younger people, makes some individuals seven times more likely to develop psychosis.
The increase in higher-potency strains of marijuana could pose unknown risks. In 1995, the average content of Tetrahydrocannabinol (THC) in confiscated marijuana was less than 4 percent. In 2022, it was more than 16 percent. Researchers don’t know the full extent of the impact that these higher concentrations can have on mental health and especially on younger people whose brains are still developing.
- A systematic review of studies published between 2013 and 2025 found damning results for the mental health of young cannabis users:
They were 51 percent more likely to experience depression, 58 percent more likely to experience anxiety, between 50 and 65 percent more likely to experience suicidal ideation and 80 to 87 percent more likely to have attempted suicide.
- While the above stats paint a grim picture, there is also some research that suggests benefits of cannabis use:
- A 2025 systematic review found that “medicinal” weed showed some efficacy in relieving withdrawal symptoms of opioid use disorder. THC use has been associated with improvement of post-traumatic stress disorder symptoms, bipolar symptoms and sleep quality.
- Other studies found that THC administered in a controlled setting was associated with a decrease of symptoms and adverse effects for a range of mental health disorders, including schizophrenia, psychotic symptoms, and anorexia nervosa.
Beyond what we pulled from academia, there is an astounding lack of information about the interplay between weed and mental health. As we dive deeper into Mental Health Awareness Month, I hope advocacy organizations, influencers and news outlets ramp up their coverage of this important topic that affects the countless LGBTQ weed smokers, many of whom are already struggling.
-
Photos5 days agoPHOTOS: Shenandoah Valley Pride
-
White House5 days agoWhite House press pool pushes back after Trump bars three outlets
-
National5 days agoLong-time DignityUSA executive director announces retirement
-
National4 days agoFor lesbian victims of domestic violence, competent care is scare
